http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-80469-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
filingDate 2004-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6ddff15e45988fe2a4430428cf7a97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971510058305e50f7930e55bbce94685
publicationDate 2007-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-80469-C2
titleOfInvention Method for the production of albumin
abstract The invention relates to a therapeutically usable virus-inactivated albumin and a method for producing a therapeutically usable virus-inactivated albumin, which is characterized by a combination of the following steps: (a) a first aqueous albumin solution is subjected to a virus inactivation treatment according to the SD method by contacting said aqueous albumin solution with SD reagents at a temperature of less than 45 DEGREE C; (b) the SD reagents are at least essentially removed by means of oil extraction and subsequent hydrophobic interaction chromatography, a hydrophobic matrix, especially a matrix to which optional hydrophobic groups can be bonded, being used for the chromatography process provided that said groups are aliphatic groups wherein C>24, and a second albumin solution is obtained to which (c) one or several stabilizers from the group comprising sugar, amino acids, and sugar alcohols is/are optionally added provided that no indole stabilizer and no C6-Cl0 fatty acid are used as stabilizers; whereupon i (d) the second albumin solution, to which stabilizer has been optionally added, is finished and sterilized by filtration and optionally filled into final containers.
priorityDate 2003-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009195
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100034206
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85302
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397731
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID247744
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280717
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID558311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798

Total number of triples: 27.